Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Down 47.3% in April

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the recipient of a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 408 shares, a drop of 47.3% from the April 15th total of 774 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,035 shares, the short-interest ratio is currently 0.2 days.

Innovator IBD Breakout Opportunities ETF Stock Performance

Shares of NYSEARCA:BOUT traded down $1.09 during trading on Friday, reaching $45.88. The company had a trading volume of 915 shares, compared to its average volume of 5,036. The firm’s fifty day moving average is $41.89 and its 200 day moving average is $39.48. The firm has a market capitalization of $16.06 million, a PE ratio of 28.69 and a beta of 1.05. Innovator IBD Breakout Opportunities ETF has a twelve month low of $34.57 and a twelve month high of $47.00.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

Several hedge funds and other institutional investors have recently added to or reduced their stakes in BOUT. Comprehensive Wealth Management LLC boosted its stake in Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares in the last quarter. Susquehanna International Group LLP raised its stake in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after buying an additional 7,817 shares in the last quarter. Finally, Osaic Holdings Inc. lifted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares during the period.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.